ey0019.8-1 | Mechanism of the year: neuropeptide substance P regulates aldosterone secretion | ESPEYB19
K Cheng , Y Seita , T Moriwaki , K Noshiro , Y Sakata , YS Hwang , T Torigoe , M Saitou , H Tsuchiya , C Iwatani , M Hosaka , T Ohkouchi , H Watari , T Umazume , K Sasaki
ey0017.2-13 | Updates on the Genetics of Neonatal Diabetes Mellitus, Congenital Hyperinsulinism and Glucose Disorders | ESPEYB17
T Pipatpolkai , S Usher , PJ Stansfeld , FM Ashcroft
ey0017.5-2 | Advances in Clinical Practice | ESPEYB17
ME Robinson , P Trejo , T Palomo , FH Glorieux , F Rauch
ey0017.8-6 | Important for Clinical Practice | ESPEYB17
V Messina , L Karlsson , T Hirvikoski , A Nordenstrom , S Lajic
ey0016.10-14 | (1) | ESPEYB16
FJ Cameron , E Russell , J McCombe , MA O'Connell , T Skinner
ey0016.14-5 | (1) | ESPEYB16
AM Ivancevic , RD Kortschak , T Bertozzi , DL Adelson
ey0015.5-8 | Fractures, vitamin D and steroids – unclear associations | ESPEYB15
N Gray , A Howard , J Zhu , LY Feldman , T To
ey0015.6-6 | New treatments | ESPEYB15
D Chew , J Anderson , K Williams , T May , K Pang
ey0015.8-15 | New Concerns | ESPEYB15
L Karlsson , A Gezelius , A Nordenström , T Hirvikoski , S Lajic
ey0015.14-8 | Imprinting without DNA methylation | ESPEYB15
A Inoue , L Jiang , F Lu , T Suzuki , Y Zhang